ロード中...
B cell depletion in treating primary biliary cirrhosis: Pros and cons
Primary biliary cirrhosis (PBC) is a progressive autoimmune liver disease of unknown etiology that affects almost exclusively women. Ursodeoxycholic acid (UDCA) is currently the only approved drug by Food and Drug Administration for patients with PBC. Although the precise pathogenesis of PBC remains...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Co., Limited
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3419989/ https://ncbi.nlm.nih.gov/pubmed/22912543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i30.3938 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|